Literature DB >> 22739230

Subclinical celiac disease and crystal-induced kidney disease following kidney transplant.

Giovanna Capolongo1, Sameh Abul-Ezz, Orson W Moe, Khashayar Sakhaee.   

Abstract

Decreased kidney function from kidney deposition of calcium oxalate has been described previously in inflammatory bowel disease and after jejuno-ileal and Roux-en-Y gastric bypass surgeries. Although celiac disease is the most prevalent bowel abnormality associated with intestinal malabsorption, its relationship to high kidney oxalate burden and decreased kidney function has not been established. We report a case of subclinical celiac disease and hyperoxaluria that presented with loss of kidney function as a result of high oxalate load in the absence of overt diarrhea, documented intestinal fat malabsorption, and nephrolithiasis. Subclinical celiac disease is commonly overlooked and hyperoxaluria is not usually investigated in kidney patients. We propose that this entity should be suspected in patients with chronic kidney disease in which the cause of kidney damage has not been clearly established. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22739230      PMCID: PMC4469185          DOI: 10.1053/j.ajkd.2012.02.342

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  29 in total

1.  Renal calculus: a unique presentation of coeliac disease.

Authors:  R Gama; F A Schweitzer
Journal:  BJU Int       Date:  1999-09       Impact factor: 5.588

2.  The effects of cimetidine on creatinine excretion, glomerular filtration rate and tubular function in renal transplant recipients.

Authors:  N V Olsen; S D Ladefoged; B Feldt-Rasmussen; N Fogh-Andersen; H Jordening; O Munck
Journal:  Scand J Clin Lab Invest       Date:  1989-04       Impact factor: 1.713

3.  Oxalate balance studies in patients on hemodialysis for type I primary hyperoxaluria.

Authors:  M Marangella; M Petrarulo; D Cosseddu; C Vitale; F Linari
Journal:  Am J Kidney Dis       Date:  1992-06       Impact factor: 8.860

4.  Clinical and pathological spectrum of coeliac disease.

Authors:  M N Marsh
Journal:  Gut       Date:  1993-12       Impact factor: 23.059

5.  Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease.

Authors:  A Ventura; G Magazzù; L Greco
Journal:  Gastroenterology       Date:  1999-08       Impact factor: 22.682

6.  Renal and intestinal transport defects in Slc26a6-null mice.

Authors:  Zhaohui Wang; Tong Wang; Snezana Petrovic; Biguang Tuo; Brigitte Riederer; Sharon Barone; John N Lorenz; Ursula Seidler; Peter S Aronson; Manoocher Soleimani
Journal:  Am J Physiol Cell Physiol       Date:  2004-12-01       Impact factor: 4.249

7.  Effect of renal transplantation on serum oxalate and urinary oxalate excretion.

Authors:  E M Worcester; S K Fellner; Y Nakagawa; F L Coe
Journal:  Nephron       Date:  1994       Impact factor: 2.847

8.  Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6.

Authors:  Zhirong Jiang; John R Asplin; Andrew P Evan; Vazhaikkurichi M Rajendran; Heino Velazquez; Timothy P Nottoli; Henry J Binder; Peter S Aronson
Journal:  Nat Genet       Date:  2006-03-12       Impact factor: 38.330

9.  Plasma profiles and dialysis kinetics of oxalate in patients receiving hemodialysis.

Authors:  M Marangella; M Petrarulo; S Mandolfo; C Vitale; D Cosseddu; F Linari
Journal:  Nephron       Date:  1992       Impact factor: 2.847

10.  Mortality in celiac disease.

Authors:  R F Logan; E A Rifkind; I D Turner; A Ferguson
Journal:  Gastroenterology       Date:  1989-08       Impact factor: 22.682

View more
  10 in total

1.  Enteric Oxalate Secretion Mediated by Slc26a6 Defends against Hyperoxalemia in Murine Models of Chronic Kidney Disease.

Authors:  Laura I Neumeier; Robert B Thomson; Martin Reichel; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  J Am Soc Nephrol       Date:  2020-07-13       Impact factor: 10.121

2.  A rare cause of nephrocalcinosis in an infant: Answers.

Authors:  Francisco Antonio Nieto-Vega; Rafael Martín-Masot; Begoña Rodríguez-Azor; Verónica Martínez-Rivera; Marta Herrador-López; Víctor Manuel Navas-López
Journal:  Pediatr Nephrol       Date:  2020-06-04       Impact factor: 3.714

3.  Adenosinergic signaling inhibits oxalate transport by human intestinal Caco2-BBE cells through the A2B adenosine receptor.

Authors:  Daniel Jung; Altayeb Alshaikh; Sireesha Ratakonda; Mohamed Bashir; Ruhul Amin; Sohee Jeon; Jan Stevens; Sapna Sharma; Wahaj Ahmed; Mark Musch; Hatim Hassan
Journal:  Am J Physiol Cell Physiol       Date:  2018-07-18       Impact factor: 4.249

4.  Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria.

Authors:  Ruhul Amin; John Asplin; Daniel Jung; Mohamed Bashir; Altayeb Alshaikh; Sireesha Ratakonda; Sapna Sharma; Sohee Jeon; Ignacio Granja; Dietrich Matern; Hatim Hassan
Journal:  Kidney Int       Date:  2018-02-01       Impact factor: 10.612

5.  The association of calcium oxalate deposition in kidney allografts with graft and patient survival.

Authors:  Ragnar Palsson; Anil K Chandraker; Gary C Curhan; Helmut G Rennke; Gearoid M McMahon; Sushrut S Waikar
Journal:  Nephrol Dial Transplant       Date:  2020-05-01       Impact factor: 5.992

6.  Loss of Cystic Fibrosis Transmembrane Regulator Impairs Intestinal Oxalate Secretion.

Authors:  Felix Knauf; Robert B Thomson; John F Heneghan; Zhirong Jiang; Adedotun Adebamiro; Claire L Thomson; Christina Barone; John R Asplin; Marie E Egan; Seth L Alper; Peter S Aronson
Journal:  J Am Soc Nephrol       Date:  2016-06-16       Impact factor: 10.121

7.  A Successful Approach to Kidney Transplantation in Patients With Enteric (Secondary) Hyperoxaluria.

Authors:  Joke I Roodnat; Anneke M E de Mik-van Egmond; Wesley J Visser; Stefan P Berger; Wilbert A G van der Meijden; Felix Knauf; Madelon van Agteren; Michiel G H Betjes; Ewout J Hoorn
Journal:  Transplant Direct       Date:  2017-11-08

8.  Enteric hyperoxaluria in chronic pancreatitis.

Authors:  Nathalie Demoulin; Zaina Issa; Ralph Crott; Johann Morelle; Etienne Danse; Pierre Wallemacq; Michel Jadoul; Pierre H Deprez
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

9.  Secondary Oxalate Nephropathy: A Systematic Review.

Authors:  Nuttha Lumlertgul; Monchai Siribamrungwong; Bertrand L Jaber; Paweena Susantitaphong
Journal:  Kidney Int Rep       Date:  2018-07-29

10.  NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy.

Authors:  Felix Knauf; John R Asplin; Ignacio Granja; Insa M Schmidt; Gilbert W Moeckel; Rachel J David; Richard A Flavell; Peter S Aronson
Journal:  Kidney Int       Date:  2013-06-05       Impact factor: 10.612

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.